Skip to main content

Mahon Paul A's Form 4 filing

United Therapeutics Corp (UTHR) · filed Apr 22, 2022

Accession no.
0001415889-22-004230
Filed
Apr 22, 2022
Trade date
Apr 21, 2022
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.14M. It was filed 1 day after the trade.

This filing was later replaced by the amendment 0001415889-23-005016 (Mar 16, 2023). Trade tables on this site use the amended version.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Mahon Paul ACIK 0001231589Officer (EVP & GENERAL COUNSEL)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 21, 2022Common StockMOption exerciseAcquired+6,000$111.00+$666,00042,487Direct
Apr 21, 2022Common StockSSaleDisposed−600$187.20F2−$112,32041,887Direct
Apr 21, 2022Common StockSSaleDisposed−1,599$188.77F3−$301,843.2340,288Direct
Apr 21, 2022Common StockSSaleDisposed−3,801$189.66F4−$720,897.6636,397Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Apr 21, 2022Common StockMOption exerciseDisposed−6,000$0.00$040,552Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This transaction was executed in multiple trades at prices ranging from $186.855 to $187.485. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F3

This transaction was executed in multiple trades at prices ranging from $188.24 to $189.20. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F4

This transaction was executed in multiple trades at prices ranging from $189.25 to $190.125. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)